课题基金 / 基金详情

Relative benefits and cost effectiveness of universal newborn screening for cytomegalovirus by saliva versus dried blood spot PCR

Relative benefits and cost effectiveness of universal newborn screening for cytomegalovirus by saliva versus dried blood spot PCR
通过唾液与干血点 PCR 进行新生儿巨细胞病毒普遍筛查的相对效益和成本效益
批准号：
379026
负责人：
Brophy Jason C
金额：
$7.29万
依托单位：
Children's Hospital of Eastern Ontario Research Institute Inc
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-10-01 至 2018-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=379026&lang=en
关键词：
Congenital Infection Cost Effectiveness Cytomegalovirus Diagnostics Newborn Screening

项目摘要

项目成果

Brophy Jason C的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
More than 1 in 200 babies in North America are born with congenital cytomegalovirus infection (cCMV). Of those infants, ~20% will develop permanent neurologic problems - cCMV causes 13-40% of all childhood hearing loss, and is second only to Down syndrome
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CPARG: Translating What We Know to Children & Families
Congenital CMV ANd HEARing in Ontario: Optimizing Screening to Improve Child Health Outcomes (CAN HEAR ONTARIO)
TrAnslating KnowledgE and inspiring ACTION for parents of children with congenital CMV in Canada: TAKE ACTION for cCMV in Canada
"CAN LhIVE WELL": The Canadian HIV Wellness Research Initiative
海外基金